Search Results - "Gobbi, Marco De"

Refine Results
  1. 1
  2. 2

    Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression by Vernimmen, Douglas, Gobbi, Marco De, Sloane-Stanley, Jacqueline A, Wood, William G, Higgs, Douglas R

    Published in The EMBO journal (18-04-2007)
    “…To understand how mammalian genes are regulated from their natural chromosomal environment, we have analysed the molecular events occurring throughout a 150 kb…”
    Get full text
    Journal Article
  3. 3

    Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment by Hughes, Jim R, Roberts, Nigel, McGowan, Simon, Hay, Deborah, Giannoulatou, Eleni, Lynch, Magnus, De Gobbi, Marco, Taylor, Stephen, Gibbons, Richard, Higgs, Douglas R

    Published in Nature genetics (01-02-2014)
    “…Douglas Higgs and colleagues report a high-throughput approach, called Capture-C, to analyze interactions between cis regulatory elements. Using Capture-C, the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Bcl‐xL represents a therapeutic target in Philadelphia negative myeloproliferative neoplasms by Petiti, Jessica, Lo Iacono, Marco, Rosso, Valentina, Andreani, Giacomo, Jovanovski, Aleksandar, Podestà, Marina, Lame, Dorela, Gobbi, Marco De, Fava, Carmen, Saglio, Giuseppe, Frassoni, Francesco, Cilloni, Daniela

    Published in Journal of cellular and molecular medicine (01-09-2020)
    “…Myeloproliferative neoplasms are divided into essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). Although ruxolitinib was…”
    Get full text
    Journal Article
  6. 6

    Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis by Camerlo, Sofia, Ligato, Jacopo, Rosati, Giorgio, Carrà, Giovanna, Russo, Isabella, De Gobbi, Marco, Morotti, Alessandro

    “…Splanchnic vein thrombosis is a rare but potentially life-threatening manifestation of venous thromboembolism, with challenging implications both at the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients by Bertolotto, Antonio, Martire, Serena, Mirabile, Luca, Capobianco, Marco, De Gobbi, Marco, Cilloni, Daniela

    Published in Neurology and therapy (01-12-2020)
    “…Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has…”
    Get full text
    Journal Article
  10. 10

    Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy by Rosati, Giorgio, Camerlo, Sofia, Dalmazzo, Matteo, Padrini, Melissa, Busana, Tiziano Tommaso, De Gobbi, Marco, Fornari, Alessandro, Morotti, Alessandro

    Published in Hematology reports (17-07-2023)
    “…Acute promyelocytic leukemia (APL) is a rare and aggressive form of acute myeloid leukemia (AML). Instead of cytotoxic chemotherapy, a combination of…”
    Get full text
    Journal Article
  11. 11

    Polycomb eviction as a new distant enhancer function by Vernimmen, Douglas, Lynch, Magnus D, De Gobbi, Marco, Garrick, David, Sharpe, Jacqueline A, Sloane-Stanley, Jacqueline A, Smith, Andrew J H, Higgs, Douglas R

    Published in Genes & development (01-08-2011)
    “…Remote distal enhancers may be located tens or thousands of kilobases away from their promoters. How they control gene expression is still poorly understood…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 by Gasparini, Paolo, Camaschella, Clara, Roetto, Antonella, Calì, Angelita, De Gobbi, Marco, Garozzo, Giovanni, Carella, Massimo, Majorano, Nunzia, Totaro, Angela

    Published in Nature genetics (01-05-2000)
    “…Haemochromatosis is a common recessive disorder characterized by progressive iron overload, which may lead to severe clinical complications. Most patients are…”
    Get full text
    Journal Article
  14. 14

    Analysis of Mesenchymal Stromal Cell Engraftment After Allogeneic HSCT in Pediatric Patients: A Large Multicenter Study by Castello, Laura M, Leone, Marco, Adamini, Aloe, Castiglia, Sara, Mareschi, Katia, Ferrero, Ivana, Marco, De Gobbi, Carnevale-Schianca, Fabrizio, Fagioli, Franca, Berger, Massimo

    Published in Journal of pediatric hematology/oncology (01-11-2018)
    “…The mesenchymal stem cell (MSC) role after allogeneic hematopoietic stem cell transplantation (HSCT) is still a matter of debate; in particular, MSC…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis by Berger, Massimo, Barone, Marta, Carnevale-Schianca, Fabrizio, De Gobbi, Marco, Nicoli, Paolo, Caravelli, Daniela, Cilloni, Daniela, Paruzzo, Luca, Spadea, Manuela, Mareschi, Katia, Aglietta, Massimo, Fagioli, Franca

    Published in Transplantology (Basel, Switzerland) (08-02-2022)
    “…HSCT from an unrelated HLA-mismatched donor (MMUD) is one of the alternatives where an HLA-matched donor is not found. The aim of this study was to compare…”
    Get full text
    Journal Article
  20. 20